Zenas BioPharma, Inc.
Ticker: 1953926
values in millions
Revenue & Profit Trend
in millionsRevenueExpenditureNet Profit
Margin Trend
percentageOPM %NPM %
| Period | Q2 FY26 | Q1 FY25 | Q3 FY23 |
|---|---|---|---|
| INCOME | |||
| Revenue | 1.00-90.0% | 10.00-80.0% | 50.00 |
| Total Income | 1.00-90.0% | 10.00-80.0% | 50.00 |
| EXPENSES | |||
| Expenditure | 108.66+129.6% | 47.33+229.1% | 14.38 |
| Tax | 0.11+152.4% | -0.21 | — |
| PROFIT | |||
| PBT | -111.34-229.6% | -33.78 | — |
| Net Profit | -111.46-232.0% | -33.57-194.3% | 35.61 |
| KEY METRICS | |||
| OPM % | -100.00% | -100.00%-171.25pp | 71.25% |
| NPM % | -100.00% | -100.00%-171.21pp | 71.22% |
| EPS | -1.77-121.2% | -0.80-133.1% | 2.42 |
Corporate Events
Board MeetingZBIO
20261Sep
Board Meeting
Appointment of Christy J. Oliger to the Board of Directors a…
SEC Filing ↗ Board MeetingZBIO
202611May
Board Meeting
2026 Annual Meeting of Stockholders to elect directors and r…
SEC Filing ↗